March 26, 2026

Limits of Negative Infection Studies in AD

Perspective argues that study design and measurement challenges may obscure potential links between infection and disease

Conexiant

March 23, 2026

Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

Conexiant

March 16, 2026

Why Copilots Failed in R&D and What Comes Next 

Organizations that benefit most from AI in R&D will be those that align technology with scientific reality

The Medicine Maker

March 13, 2026

Clinicians Warn of Fatal Measles Brain Disease

Doctors caution that measles infection can lead to SSPE, a rare fatal neurologic disease that may appear years later.

KFF Health News

March 12, 2026

The New Blueprint for Vaccine Development

ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness

The Medicine Maker

February 13, 2026

What Was Promised at Confirmation?

After pledging to uphold vaccine policy and funding, RFK Jr. has reshaped advisory panels, research priorities, and immunization guidance.

KFF Health News

February 09, 2026

How Language Shapes Care 

ACP examines ethical implications of calling all physicians “providers”

Conexiant

February 05, 2026

Five Ways AI Will Reshape Life Sciences in 2026

Why people, process, and purpose matter most

The Medicine Maker

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 27, 2026

The Exam Room Is Listening Now

As AI quietly enters exam rooms, physicians report real relief—and real concerns about accuracy, trust, and control.

KFF Health News